Department of Parasitology, Medical Research Institute, University of Alexandria, Alexandria, Egypt.
Department of Microbiology, Medical Research Institute, University of Alexandria, Alexandria, Egypt.
Trop Med Int Health. 2021 Jun;26(6):632-639. doi: 10.1111/tmi.13562. Epub 2021 Mar 31.
To assess the status of intestinal schistosomiasis among preschool-aged (PSAC) and school-aged children (SAC) and to compare the efficacy of praziquantel (PZQ) in both groups.
The study was conducted on 400 children; 103 PSAC and 297 SAC. Diagnosis of Schistosoma mansoni was based on triplicate Kato-Katz thick smears from a single stool sample. To identify the missed cases by Kato-Katz, 120 randomly selected negative cases (38 PSAC and 82 SAC) were screened by real-time PCR. All S. mansoni-positive cases by Kato-Katz were treated by crushed PZQ tablets. Four weeks after treatment, the cure rate was assessed by Kato-Katz smears and real-time PCR.
The prevalence of S. mansoni with Kato-Katz was 7.8% among PSAC and 7.4% among SAC. Most of children (63.3%) had light-intensity infection. The cure rate was 100% among PSAC by both techniques, and 91%, and 77.2% among SAC by Kato-Katz and real-time PCR, respectively. In the 120 stool samples screened by real-time PCR, S. mansoni prevalence was 25%; 15.8% and 29.3% were among PSAC and SAC respectively. Treated cases showed a lower range of Ct values than untreated cases. Two melting temperature ranges (Tm = 83-87°C and 89-93°C) were recognised among uncured cases which may point to S. mansoni genetic variability.
Continuous monitoring and inclusion of PSAC in schistosomiasis control programmes are crucial. Real-time PCR and other molecular tools are recommended for evaluation of the true prevalence, assessment of cure and further studies on genetic diversity.
评估学龄前儿童(PSAC)和学龄儿童(SAC)的肠道血吸虫病感染状况,并比较吡喹酮(PZQ)在两组中的疗效。
本研究纳入了 400 名儿童,其中 103 名为 PSAC,297 名为 SAC。曼氏血吸虫病的诊断基于单个粪便样本的三重 Kato-Katz 厚涂片。为了发现 Kato-Katz 漏检的病例,对 120 例随机选择的阴性病例(38 例 PSAC 和 82 例 SAC)进行了实时 PCR 筛查。所有 Kato-Katz 阳性的曼氏血吸虫病患者均采用粉碎的 PZQ 片剂进行治疗。治疗 4 周后,采用 Kato-Katz 涂片和实时 PCR 评估治愈率。
PSAC 中曼氏血吸虫病的 Kato-Katz 流行率为 7.8%,SAC 中为 7.4%。大多数儿童(63.3%)感染程度较轻。两种技术均显示 PSAC 的治愈率为 100%,而 SAC 的治愈率分别为 Kato-Katz 法 91%和实时 PCR 法 77.2%。在实时 PCR 筛查的 120 份粪便样本中,曼氏血吸虫病的流行率为 25%;PSAC 和 SAC 中的感染率分别为 15.8%和 29.3%。治疗组的 Ct 值范围低于未治疗组。未治愈组中发现了两个解链温度范围(Tm=83-87°C 和 89-93°C),这可能表明曼氏血吸虫的遗传变异。
持续监测和将 PSAC 纳入血吸虫病控制规划至关重要。建议使用实时 PCR 和其他分子工具来评估真实的流行率、评估治愈率以及进一步研究遗传多样性。